(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ICANJECT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ICANJECT

ST13

US500000079406800

Class

5, 10

Filing

79406800

Registration

7718090

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

04/03/2026

Classification

Registered

Trademark type

Word

Nice classes

5, 10

Filing date

07/17/2024

Registration date

03/11/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/11/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

WELLS, KELLEY L

Law office

M90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

NOVARTIS AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and medical preparations and medical devices sold pre-filled with pharmaceutical preparationsall for the prevention and treatment of renal diseases and disordersinflammatory diseases and disordersdermatological diseases and disordersgastrointestinal diseases and disordersrespiratory diseases and disorderscomplement-mediated diseases and disordersneoplastic diseases and disordersbone diseases and disordersdiseases and disorders of the immune systemthe cardiovascular systemthe musculo-skeletal systemthe genitourinary systemthe central nervous systemthe endocrine systemthe metabolic system and the circulatory system

Class 10

Autoinjectors for the administration of pharmaceutical preparations

Publications

History of USPTO decisions and trademark events.

21 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/02/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/16/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

03/16/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/10/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

03/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/21/2025

PUBO

PUBLISHED FOR OPPOSITION

01/21/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/15/2025

ISCR

WITHDRAWN FROM ISSUE - OG REVIEW QUERY

01/10/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/21/2024

DOCK

ASSIGNED TO EXAMINER

12/21/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/06/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/06/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/06/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/06/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/06/2024

MAFR

APPLICATION FILING RECEIPT MAILED

10/24/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/24/2024

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

10/23/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/17/2024

Continuous trademark protection

Get notified about every new filing that threatens ICANJECT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.